A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period
Autor: | Ai Matsui, Yayoi Yamamoto, Soji Toda, Hiroyuki Iwasaki, Daisuke Murayama, Mio Yasukawa |
---|---|
Rok vydání: | 2021 |
Předmět: |
Sodium-iodide symporter
medicine.medical_specialty Mammary gland Breastfeeding R895-920 chemistry.chemical_element Case Report Ablation Iodine Thyroid cancer Thyroid carcinoma Excretion Medical physics. Medical radiology. Nuclear medicine Internal medicine Lactation Medicine Radiology Nuclear Medicine and imaging Gastrointestinal tract business.industry medicine.disease medicine.anatomical_structure Endocrinology chemistry Radioactive iodine business |
Zdroj: | Radiology Case Reports, Vol 16, Iss 11, Pp 3442-3444 (2021) Radiology Case Reports |
ISSN: | 1930-0433 |
DOI: | 10.1016/j.radcr.2021.08.035 |
Popis: | The accumulation of 131-iodine is known to occur in the extrathyroidal tissues, such as the salivary glands and the gastrointestinal tract during radioactive iodine therapy. It is considered to be due to the expression of sodium iodide symporter. A 36-year-old lactating female was treated for remnant ablation for papillary thyroid carcinoma (pT1bN1bM0 pStage I) on the condition that she refrained from breastfeeding and was separated from her child and was milked to promote the excretion of 131-iodine until the accumulation disappeared on scintigram imaging. Scintigram showed the decrease and disappearance of the 131-iodine accumulation and the external dose rate was measured and confirmed to have decreased on the day 7 and 14 after the treatment. In conclusion, remnant ablation may be available by milking and separation from the child for 7 to 14 days. |
Databáze: | OpenAIRE |
Externí odkaz: |